News & Updates

Patients who have had to delay their intravenous thrombolysis (IVT) procedures due to the COVID-19 pandemic suffer from worse short-term clinical outcomes such as higher rates of mortality and hospice care, reports a study presented at the Annual Meeting of the American Academy of Neurology (AAN 2022). These patients are also less likely to be discharged to their homes or to rehabilitation facilities.

The risk of developing heart failure appears to increase in proportion with the level of obesity, especially among women whose menopause occurred at ≥55 years of age, a study has found.

Novel measures of left atrial (LA) structure and function, but not standard assessment by LA maximal (LAViMax), appear to be prognostic of a higher risk of incident heart failure (HF) or death, irrespective of measures of left ventricular function and N-terminal pro‒B-type natriuretic-peptide (NT-proBNP), suggests a recent study.

In the treatment of ischemic symptoms associated with peripheral arterial disease, the use of once-daily SID142 appears to be as good as twice-daily Renexin while having a favourable safety profile, as shown in a phase III study.

An intervention aimed at reducing sodium intake in patients with heart failure (HF) does not reduce the risk of emergency department (ED) presentation or hospitalization for cardiovascular (CV) causes or all-cause death, according to results of the SODIUM-HF* trial. However, patients did experience improvements in quality of life (QoL) and New York Heart Association (NYHA) class.